Industries

Mass Spectrometry and Proteomics

Mass spectrometry-based proteomics and metabolomics have become cornerstones of clinical biomarker discovery, pharmaceutical quality control, and systems biology. Leading instrument makers partner with university proteomics centers for application development, often co-authoring methods papers that demonstrate new hardware capabilities in high-impact biological contexts.

Details

Companies

Bruker DaltonicsThermo Fisher Scientific OrbitrapWaters ACQUITYSCIEX TripleTOFProtein MetricsBiognosysProteome SciencesQuanterixOLink ProteomicsOncoC4

Market Size

$6.5B

Target Researchers

Analytical biochemists and proteomics researchers specializing in LC-MS/MS, data-independent acquisition, top-down proteomics, post-translational modification analysis, clinical biomarker discovery, and metabolomics workflows

Use Cases

Clinical proteomics biomarker partnershipDIA software and workflow licensingProteomics CRO servicesMS instrument beta-testing partnershipsMulti-omic data analysis platform integrationProtein quantification reference material supply